OCUL
Price
$11.07
Change
+$0.64 (+6.14%)
Updated
Jan 14 closing price
Capitalization
2.36B
53 days until earnings call
Intraday BUY SELL Signals
PLRX
Price
$1.31
Change
+$0.02 (+1.55%)
Updated
Jan 14 closing price
Capitalization
80.5M
47 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OCUL vs PLRX

Header iconOCUL vs PLRX Comparison
Open Charts OCUL vs PLRXBanner chart's image
Ocular Therapeutix
Price$11.07
Change+$0.64 (+6.14%)
Volume$7.1M
Capitalization2.36B
Pliant Therapeutics
Price$1.31
Change+$0.02 (+1.55%)
Volume$826.19K
Capitalization80.5M
OCUL vs PLRX Comparison Chart in %
OCUL
Daily Signal:
Gain/Loss:
PLRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OCUL vs. PLRX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCUL is a Hold and PLRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (OCUL: $11.07 vs. PLRX: $1.31)
Brand notoriety: OCUL and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OCUL: 209% vs. PLRX: 62%
Market capitalization -- OCUL: $2.36B vs. PLRX: $80.5M
OCUL [@Biotechnology] is valued at $2.36B. PLRX’s [@Biotechnology] market capitalization is $80.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OCUL’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • OCUL’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, OCUL is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OCUL’s TA Score shows that 2 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • OCUL’s TA Score: 2 bullish, 7 bearish.
  • PLRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PLRX is a better buy in the short-term than OCUL.

Price Growth

OCUL (@Biotechnology) experienced а -3.74% price change this week, while PLRX (@Biotechnology) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.31%. For the same industry, the average monthly price growth was +3.20%, and the average quarterly price growth was +43.69%.

Reported Earning Dates

OCUL is expected to report earnings on Mar 09, 2026.

PLRX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($2.36B) has a higher market cap than PLRX($80.5M). PLRX YTD gains are higher at: 7.377 vs. OCUL (-8.814). PLRX has higher annual earnings (EBITDA): -170.45M vs. OCUL (-233.54M). OCUL has more cash in the bank: 345M vs. PLRX (242M). PLRX has less debt than OCUL: PLRX (59.9M) vs OCUL (77M). OCUL has higher revenues than PLRX: OCUL (55.8M) vs PLRX (0).
OCULPLRXOCUL / PLRX
Capitalization2.36B80.5M2,935%
EBITDA-233.54M-170.45M137%
Gain YTD-8.8147.377-119%
P/E RatioN/AN/A-
Revenue55.8M0-
Total Cash345M242M143%
Total Debt77M59.9M129%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OCULPLRX
RSI
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 7 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 29 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
83%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
OCUL
Daily Signal:
Gain/Loss:
PLRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSPCY5.090.16
+3.25%
CSPC Pharmaceuticals Group Ltd.
EUTLF2.750.02
+0.73%
Eutelsat Communications
PBKOF14.54N/A
N/A
Pollard Banknote Ltd.
SKFG0.07N/A
N/A
STARK FOCUS GROUP INC.
HWAUF0.51-0.01
-1.29%
Headwater Gold Inc.

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with WVE. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then WVE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
+6.14%
WVE - OCUL
56%
Loosely correlated
+2.04%
NRIX - OCUL
54%
Loosely correlated
+0.58%
KYMR - OCUL
52%
Loosely correlated
+1.46%
IDYA - OCUL
51%
Loosely correlated
+5.53%
EYPT - OCUL
50%
Loosely correlated
-0.06%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with LXRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then LXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+1.55%
LXRX - PLRX
42%
Loosely correlated
+3.33%
FHTX - PLRX
40%
Loosely correlated
-5.54%
OCUL - PLRX
37%
Loosely correlated
+6.14%
SLDB - PLRX
37%
Loosely correlated
+12.60%
ACHV - PLRX
36%
Loosely correlated
+1.63%
More